Performance of a Semi-quantitative Multiplex Bacterial PCR Panel Compared with Standard Microbiological Laboratory Results: 396 Patients Studied with the BioFire® Pneumonia Panel
Abstract Background Microbiologic results are critical to optimal management of patients with lower respiratory tract infection, but standard methods may take several days. The multiplex PCR BioFire® Pneumonia (PN) panel detects 15 common bacterial species semi-quantitatively as copy number/mL, 8 viral species and 7 resistance genes in about an hour within the clinical laboratory. Methods We tested 396 unique endotracheal or bronchoalveolar lavage specimens with the BioFire® Pneumonia panel, and compared the bacterial detections to conventional gram stain and culture results. Results Of the 396 patients, 180 grew at least 1 bacteria that had a target on the PN panel and 177/180 (98.3%) were detected by the panel. A further 20% of patients had additional targets detected, but not found in standard culture (specificity 69%, positive predictive value 63%, and negative predictive value 98.9%). Copy number was strongly related to standard semi-quantitative growth on plates reported by the laboratory (e.g. 1+, 2+, 3+ growth), and was significantly higher in those specimens that grew a potential pathogen. Both higher copy number and bacterial detections found by the PN panel, but not found in culture, were strongly positively related to the level of WBC reported in the initial gram stain. Conclusions Higher copy number and bacterial detections per se by the PN panel are related to the host respiratory tract inflammatory response. If laboratories can achieve a rapid turnaround time, the PN panel should have a significant impact both to patient management and to antibiotic stewardship.